华峰化学（002064）：氨纶盈利韧性凸显，己二酸短期承压，业绩符合预期

Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Views - The company's performance in the first half of 2025 met expectations, with total revenue of 12.14 billion yuan, a year-on-year decrease of 12%, and a net profit attributable to shareholders of 983 million yuan, down 35% year-on-year [6] - The demand for spandex is growing, but prices remain under pressure, highlighting the company's resilient profitability amid industry challenges [6] - The company's gross profit from spandex reached 786 million yuan in the first half of 2025, with a gross margin of 18.65%, benefiting from cost advantages due to scale and technology [6] - The price and profitability of adipic acid are under pressure due to weak demand, but the company expects a recovery in the industry environment [6] - The company is a leading player in the global spandex, adipic acid, and polyurethane raw materials market, with significant scale, technology, and cost advantages [6] Financial Summary - For 2025, the company is projected to have total revenue of 24.38 billion yuan, a year-on-year decrease of 9.5%, and a net profit of 2.53 billion yuan, with an expected EPS of 0.51 yuan per share [5][8] - The gross margin is expected to improve to 15.0% in 2025, with a return on equity (ROE) of 8.7% [5] - The company's market capitalization corresponds to a price-to-earnings ratio (PE) of 15 times for 2025, which is lower than the average PE of comparable companies at 46 times [5]